Pulmonary embolism. What is the treatment of pulmonary embolism?

Pulmonary embolism. What is the treatment of pulmonary embolism?

Treatment of massive embolism and submasivniya is conducted with fibrinolytics or operational - by embolectomy. The last is removed directly from the pulmonary vascular emboli in the extracorporeal circulation conditions.
 

Fibrinolytics are several - streptokinase, urokinaza, tissue plasminogen activator. Indications for their use include the presence of hemodynamic instability, acute right heart failure. Used regimen for 24 hours followed by treatment with anticoagulants.

In nemasivnen lung trombemolizam starting with direct anticoagulant - heparin or LMWH. Heparin is a glycosaminoglycan that binds antithrombin III and inhibits certain coagulation factors (thrombin and Xa). Therapeutic effects were observed by monitoring the kind laboratory coagulation parameters - partsialnno activated thromboplastin time, namely by increasing it from 1.5 to 2 times higher than normal. For most rapid effect is applied first heparin bolus dose of 5-10 Hill, followed by infusion at 1000-1800E/chas control aPTT. The duration of treatment is individual, at least 7 days.

Prophylactic doses of the order of h 1500E/24 applied in high risk patients.

Low molecular weight heparins have several Advantages to heparin - have a longer biological half-life, more pronounced anticoagulant activity, applied subcutaneously once or twice daily in a fixed dose without the need for laboratory monitoring. Used in chronic-recurrent forms of pulmonary embolism, and for the treatment of PE submasivniya in its prevention in at-risk groups.

Treatment with heparin are at risk of bleeding in saprovozhdashi disease or overdose. As a side effect can be observed thrombocytopenia. There have been allergic reactions. Long-term use - for months, carries the risk of osteoporosis.

Antidote for heparin is protaminsulfatat (1ml-10mg neutralize heparin 1000).

Indirect anticoagulants act by inhibiting vitamin K-dependent coagulation factors. Therapeutic effect is achieved within 36 to 72 hours of application, so that it starts during direct anticoagulant therapy. Anticoagulants - Sintrom, Wafrarin ¸ apply schemes as their effects are observed by monitoring prothrombin time predsstaveno as INR - 2-3. Monitoring is often needed in the beginning, then every 2 weeks or more. Indirect anticoagulant was administered 3 months to 1 year.,

Putting a filter in the bottom empty vein is indicated in patients in whom the use of anticoagulants is strictly contraindicated - recent bleeding, soon carried out, hemorrhagic shock, and others.; Patients experienced massive embolism, in which a second such episode will be fatal, patients with recurrent venous thromboembolism, irrespective of anticoagulation.

No comments:

These articles are informative and can not replace a medical consultation.